The Symposium will be held in Marseille, France, on 20-21 September 2013.
Despite the rarity of this condition, much emphasis has recently been placed by medical institutions and research faculties around the world upon its treatment and cure, perhaps because it both serves as a model of lesion-based epilepsy, and provides a particular challenge to neurosurgeons.
Significant advances in research and surgical treatment have been made since the Ist International Symposium more than ten years ago, and this IInd International Symposium will provide a platform for collaboration and education and offer an opportunity to set a road-map for the next ten years of treatment and research.
This Symposium devoted to the treatment of hypothalamic hamartomas is a further expression of the hope that the neurological and neurosurgical communities are giving to patients and families through the continuing development of treatments that will improve their quality of life.
|Prof. Jean Régis||Prof. John F. Kerrigan|